| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2009 | EP2012783A1 Mono and combination therapy with m1/m4 muscarinic agonist (sabcomeline) for treatment of prodromal syndrome |
| 01/14/2009 | EP2012782A1 USE OF IMIDAZO[2,1-b)]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN |
| 01/14/2009 | EP2012781A2 Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate |
| 01/14/2009 | EP2012780A2 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 01/14/2009 | EP2012779A2 Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (vr1) receptors |
| 01/14/2009 | EP2012778A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 01/14/2009 | EP2012777A2 Process for the synthesis of (+) and (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane |
| 01/14/2009 | EP2012776A2 9a-substituted azalides |
| 01/14/2009 | EP2012775A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators |
| 01/14/2009 | EP2012774A1 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 01/14/2009 | EP2012773A2 Drugs and uses |
| 01/14/2009 | EP2012772A1 Reducing cancer cell invasion using an inhibitor of toll like receptor signaling |
| 01/14/2009 | EP2012771A2 Nanoemulsion vaccines |
| 01/14/2009 | EP2012770A2 Trivalent chromium compounds, compositions and methods of use |
| 01/14/2009 | EP2012769A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms |
| 01/14/2009 | EP2012768A1 Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures |
| 01/14/2009 | EP2012767A2 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye |
| 01/14/2009 | EP2012766A2 Inhibition of jak2 as a treatment of pulmonary arterial hypertension |
| 01/14/2009 | EP2012765A2 Compositions and methods useful for treatment of respiratory illness |
| 01/14/2009 | EP2012764A1 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol |
| 01/14/2009 | EP2012763A1 Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid |
| 01/14/2009 | EP2012762A2 Intranasal administration of ketamine to treat depression |
| 01/14/2009 | EP2012761A1 Statins for the treatment of viral influenza infections |
| 01/14/2009 | EP2012760A2 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/14/2009 | EP2012759A1 Purine derivatives as a2a receptor agonists |
| 01/14/2009 | EP2012758A2 Inhibitors of the task-1 and task-3 ion channel |
| 01/14/2009 | EP2012757A2 Asymmetric membranes for drug delivery devices |
| 01/14/2009 | EP2012756A2 Multiple unit compositions |
| 01/14/2009 | EP2012754A1 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles |
| 01/14/2009 | EP2012751A2 Novel nanoparticles for delivery of active agents |
| 01/14/2009 | EP2012749A2 Pharmaceutical composition containing a taxane derivative, destined for the preparation of an infusion solution, method of preparation thereof and use thereof |
| 01/14/2009 | EP2012706A2 Pharmaceutical formulations for iontophoretic methotrexate delivery |
| 01/14/2009 | EP2012705A2 Pharmaceutical formulations for iontophoretic drug delivery |
| 01/14/2009 | EP2012587A2 Cancer treatment method |
| 01/14/2009 | EP1969122A4 Controlling toxicity of aminoquinoline compounds |
| 01/14/2009 | EP1917242B1 Azabicyclo [3.1.0]hexylphenyl derivatives as modulators of dopamine d3 receptors |
| 01/14/2009 | EP1898917B1 Aminopyrimidines as kinase modulators |
| 01/14/2009 | EP1888063B1 Antifungal agents |
| 01/14/2009 | EP1874281A4 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| 01/14/2009 | EP1844050B1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 01/14/2009 | EP1811956A4 Method of reducing nosocomial infections |
| 01/14/2009 | EP1809600A4 Cyclic b-amino acid derivatives as factor xa inhibitors |
| 01/14/2009 | EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 01/14/2009 | EP1687642B1 Screening methods for combinations of biological compounds |
| 01/14/2009 | EP1686989B1 Use of 1,2-diaza-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/14/2009 | EP1684742B1 Use of 1-oxadibenzo [e,h] azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/14/2009 | EP1668014B1 Fused heterocyclic compounds as serotonin receptor modulators |
| 01/14/2009 | EP1663974B1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
| 01/14/2009 | EP1651221B1 Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| 01/14/2009 | EP1648430A4 Treatment of premature ejaculation |
| 01/14/2009 | EP1646365B1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
| 01/14/2009 | EP1641443B1 Cosmetic and/or pharmaceutical composition comprising dimthylsulphone and a sunscreen for the cure and prevention of irritation, inflammation and cutaneous erythema |
| 01/14/2009 | EP1622894B1 Antitumoral antiandrogenic pyrrolidines |
| 01/14/2009 | EP1613641B1 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 01/14/2009 | EP1602404B1 Medicament in fine particle form, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 01/14/2009 | EP1601350B1 Titration dosing regimen for controlled release tramadol |
| 01/14/2009 | EP1588707B1 Stable solid medicinal composition for oral administration of ramosetron |
| 01/14/2009 | EP1575532A4 Mixed esters of dicarboxylic acids for use as pigment dispersants |
| 01/14/2009 | EP1567164B1 Use of loxapine for the manufacture of a medicament for the treatment of pain |
| 01/14/2009 | EP1565179B1 Composition comprising a carbamic acid derivative, its use as cosmetic and medicine |
| 01/14/2009 | EP1565173B1 Composition and its use for treating neuropathic sensory loss |
| 01/14/2009 | EP1560584B1 Fab i inhibitors |
| 01/14/2009 | EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 01/14/2009 | EP1516620B1 Rifampicin for treating angiogenesis |
| 01/14/2009 | EP1513804B1 Novel trans-lutein enriched xanthophyll ester concentrate and a process for its preparation |
| 01/14/2009 | EP1497309B1 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 01/14/2009 | EP1487486B1 Imidazoquinolineamines as adjuvants in hiv dna vaccination |
| 01/14/2009 | EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
| 01/14/2009 | EP1466900B1 2-substituted vitamin d derivatives |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1451151B1 Hydroperylene derivatives |
| 01/14/2009 | EP1436291B1 Indolizines as kinase protein inhibitors |
| 01/14/2009 | EP1430025B1 Methods and compositions for treating or preventing bacterial infection |
| 01/14/2009 | EP1429915B1 Systems, methods and apparatuses for manufacturing dosage forms |
| 01/14/2009 | EP1429769B1 New formulations and use thereof |
| 01/14/2009 | EP1395567B1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 01/14/2009 | EP1348428B1 Powdery preparations and process for producing the same |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1331221B1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 01/14/2009 | EP1323716B1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1311241B1 Use of a porous carrier |
| 01/14/2009 | EP1301523B1 N8 - and c8 -linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotide hybridization |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | EP1278537B1 Compositions for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| 01/14/2009 | EP1258484B1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 01/14/2009 | EP1233948B1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/14/2009 | EP1187918B2 Tek antagonists |
| 01/14/2009 | EP1183025B1 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 01/14/2009 | EP1159952B1 N-Acetylhydroxyproline for improving the moisture retention function of the epidermis |
| 01/14/2009 | EP1146913B1 Conjugates of granulocyte colony stimulating factors for targeting and imaging infection and inflammation |
| 01/14/2009 | EP1131337B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
| 01/14/2009 | EP1087768B1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 01/14/2009 | EP0908181B1 Remedy for rosacea |
| 01/14/2009 | EP0841937B2 Use of betaglycan to reduce scarring |
| 01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
| 01/14/2009 | CN201179205Y Diclofenac sodium dual-release capsule tablet |